Evidence map›Paper›PMID 38057373›Full record

ArticleScientific reports2023

A natural product YSK-A blocks SARS-CoV-2 propagation by targeting multiple host genes.

Thuy X Pham, Trang T X Huynh, Bumseok Kim, Yun-Sook Lim, Soon B Hwang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. The Binding of Brazilin fromInternational journal of molecular sciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thuy X Pham *Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea.
Trang T X Huynh *Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea.
Bumseok KimLaboratory of Veterinary Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan, South Korea.
Yun-Sook LimLaboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea. yunsolim@hanmail.net.
Soon B HwangLaboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea. sbhwang@jbnu.ac.kr.
Jeonbuk National University · KRHallym University · KR

Funding

Ministry of Science and ICT, South Korea 2021R1A2C2003275Ministry of Science and ICT, South Korea 2022R1A2B5B01001390
6 · The paper itself

Abstract

Natural products and herbal medicine have been widely used in drug discovery for treating infectious diseases. Recent outbreak of COVID-19 requires various therapeutic strategies. Here, we used YSK-A, a mixture of three herbal components Boswellia serrata, Commiphora myrrha, and propolis, to evaluate potential antiviral activity against SARS-CoV-2. We showed that YSK-A inhibited SARS-CoV-2 propagation with an IC

Indexed as

Biological ProductsCOVID-19Plants, MedicinalAnimalsAntiviral AgentsChlorocebus aethiopsSARS-CoV-2Vero CellsAntiviral AgentsBiological Products

Identifiers

PMID38057373
PMCPMC10700534
OpenAlexW4389397937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.